Retinal proteins -You can teach an old dog new tricks Over three hundred proteins in prokaryotic and eukaryotic organisms use vitamin-A aldehyde (retinal) to carry out their biological function in response to light. These retinylidene proteins, commonly called rhodopsins, mediate such diverse processes as ion transport and phototaxis signaling in microorganisms, or various types of photosignal transduction in higher animals, most importantly vision. Retinylidene proteins are among the relatively few families of membrane proteins for which structural information is available from crystallography. Today, the possibility of using a wide range of time-resolved molecular spectroscopy assays and state-of-the art molecular dynamics simulations will help complement the now largely static view of retinal protein function with information on the conformational changes that lead to protein activation. In the end, "… the realization of animate matter requires certain (molecular) structures upon which the higher-order structures are built, but the guiding principle (of biology) is function rather than structure." [Manfred Eigen, From Strange Simplicity to Complex Familiarity: A Treatise on Matter, Information, Life and Thought, 2013, Oxford University Press, Prolegomenon].
Clemens Glaubitz present a comprehensive view on the structure and mechanism of the proton-pumping proteorhodopsin. Victor Lorenz-Fonfria and Joachim Heberle discuss the gating mechanism of channelrhodopsin, the latter presenting a new functionality for retinal proteins as channelrhodopsin acts as a light-gated cation channel. Coral del Val, Jose Royuela-Flor, Stefan Milenkovic, & Ana-Nicoleta Bondar used bioinformatics tools to dissect conservation motifs and homology models of channelrhodopsins.
The reviews on the structure and function of microbial rhodopsins are complemented by an overview on the usage of retinal proteins as model systems to understand folding of membrane proteins. Oznur Tastan, Arpana Dutta, Paula Booth & Judith Klein-Seetharaman have integrated experimental and computational methods to provide a comprehensive view on the current status of retinal protein folding.
Our collection of reviews on rhodopsin concludes with a series of five papers on diverse aspects of mammalian rhodopsins, ranging from physiology to structure and function. Yasushi Imamoto & Yoshinori Shichida discuss the unique properties of cone visual pigments, the photoreceptor molecules responsible for photopic vision. Xavier Deupi builds a case on why the dim-light photoreceptor rhodopsin remains an important model system for the study of the important family of Class A (or "rhodopsin-like") G protein-coupled receptors. The next two reviews examine some of the spectroscopy techniques used to study the light-activation activation mechanism in rhodopsins: Andreyah Pope, Markus Eilers, Philip J. Reeves & Steven O. Smith describe the use of solid-state NMR spectroscopy, whereas Ulrike Alexiev and David L. Farrens summarize the basis, challenges and opportunities of fluorescence spectroscopy. Finally, Mitsumasa Koyanagi and Akihisa Terakita discuss the properties and physiology of nonvisual opsin-based pigments, and their potential for optogenetic applications.
The picture that emerges from this special issue on retinal proteins is that, despite the long history of research in the field, rhodopsins remain at the forefront of several state-of-the-art fields: Proteorhodopsins abound in the oceans and may have played a role in early photosynthesis, channelrhodopsins are at the foundation of the new field of optogenetics, and a mammalian rhodopsin helps us understand how point mutations translate to protein malfunction and disease. Progress in the understanding of retinal protein structure and function was always accompanied by methodological advances. -cryo-electron microscopy, cubic phase crystallization, QM/MM simulations, solid-state NMR and time-resolved vibrational spectroscopies (IR and Raman), to name just a few. Retinal proteins will certainly continue to play an important role in the development of time-resolved pump-probe experiments using X-ray freeelectron lasers, a technique that will allow obtaining information on membrane protein activation at an unprecedented temporal and spatial resolution. As an additional example, a mammalian rhodopsin has been the first (and so far only) G protein-coupled receptor for which the structure of disease-related mutants has been solved, leading the way to understand how point mutations translate to protein malfunction and disease. Such developments augur a luminous future for the field of retinal protein research.
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